We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

When it comes to recipes, I have a few nonnegotiables: simple, healthy and delicious! These creations are terrific for when you’re craving a quick breakfast or scrumptious afternoon snack: my ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

In this article, we are going to take a look at where Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) stands against the other small cap pharma stocks. Emily Field, Head of European Pharma Research ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report), with a price target of $36.00. The company’s ...

Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report) today. The company’s shares closed yesterday at $31.49. See what stocks are ...

Amphastar Pharmaceuticals (AMPH) reported $186.52 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.7%. EPS of $0.92 for the same period compares ...

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.88 per share a year ago.

It hasn't been the best quarter for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) shareholders, since the share price has fallen 29% in that time. But that doesn't change the fact that the returns ...

Over the past 90 days, revenue estimates for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) have declined from $737.66 million to $734.23 million for the full year 2024 and from $806.58 million to $ ...